Claris Lifesciences Limited IPO Message Board (Page 22)

Considering the current market sentiments and trend
one should stay away from these type of IPOs
and apply only in blue chip company

Remember it is always important to protect ur money rather than earning

kostak rate of moil and claris life ?

Mr KK Natarajan @ 55:

For Long Term: Do NOT buy
For Listing Gain: Buy, if AQB subscrption is more tha 20 times

Mr danish dreamz @ 65: FPO of SCI closes on 3rd and Hind Copper on 9th Dec 10.

@ all experts here...
if we apply this ipo then can we apply for shiping corp ipo with the refund of claris??? will i be able to get the refund untill 7 dec???

can we subscribe to that ipo?

Forthcoming Issues at NSE

CLARIS LIFESCIENCES LIMITED

Symbol - Series      CLARIS EQ
Issue Period      Nov 24, 2010 to Nov 26 2010
Post issue Modification Period      27-Nov-10
Issue Size      Public Issue Of [.] Equity Shares Of Rs. 10 Each Aggregating To Rs. 3000 Million.
Issue Type      100% Book Building
Price Range      Rs 278 to Rs 293
Tick Size      Re. 1/-
Market Lot      22 Equity Shares
Minimum Order Quantity      22 Equity Shares
Maximum Subscription Amount for Retail Investor      Rs.200000
IPO Market Timings      10.00 a.m. to 5.00 p.m.
IPO Grading      IPO Grade 3
Rating Agency      Fitch Ratings India Private Limited
Book Running Lead Manager      Enam Securities Private Limited,Edelweiss Capital Limited,JM Financial Consultants Private Limited,ICICI Securities Limited.
Syndicate Member      Edelweiss Securities Limited,JM Financial Services Private Limited.
Categories      FI,IC,MF,FII,OTH,CO,IND, and NOH.
No. of Cities with Bidding Centers      47
Name of the registrar      Link Intime India Private Limited
Address of the registrar      C 13, Pannalal Silk Mills Compound,LBS Marg, Bhandup (West),Mumbai 400 078
Contact person name number and Email id      Mr. Sachin Achar,Tel: 91 22 2596 3838, Fax: 91 22 2594 6979 E-Mail:cll.ipo@linkintime.co.in

Dear Gane,
My friend's full amt was released in ASBA for gravita issue but after he checked in the karvy allotment status he got 50 shares after wards 6250 was debited.SBI ASBA is peculiar.

Even the employees of so called new age banks are unaware of ASBA. their first reaction is ? What's it. HDFC bank has implemented (some what crude) it in their net banking/online system now, but ICICI bank is still shying?

@kalaimala
I fully agree with you. Most SBI employees are not aware of ASBA. While applying for Coal India IPO offline I literally compelled the Branch Manager of SBI, Sambalpur to let me avail of the facility. He repeatedly asked me to apply through cheque/DD but I refused. I compelled him to contact SBI Higher ups and activate ASBA in his branch which he was very reluctant to do. Finally after much coaxing for two days he did accept my application thru ASBA on 20th Oct. Mine was the first case to apply in ASBA off line from Sambalpur, Orissa.
The fault lies with the SBI staff who donot want to be technically updated. Who wants to take extra load?
The public also is not very insistent.
Come on guys let's press SBI to come of age.

Considering the PE Ratio Means consider Orchid Chemicals & Pharmaceuticals Ltd, which is Available @ 306, PE of 6.30.........

Salecha,
good idea

We invested Rs.45,000 in their Core Healthcare / Parenteral. Now that share certificate, even a donkey will not eat.

AHMEDABAD: Ahmedabad-based critical care and hospital products maker, Claris Lifesciences Ltd , has finally received approval from Securities and Exchange Board of India (SEBI) for its maiden public issue to raise Rs 300 crore.

It was in January 2008, that the then CEO and founder of Claris Lifesciences, Sushil Handa first planned an IPO. However, the plan was put on a backburner. Later, in May 2009, global pharma giant Pfizer Inc entered into a 15-year marketing tie-up for 15 products with Claris. The injectable generic market is estimated at $29 billion in US, followed by Germany and UK estimated at $14.9 billion and $6.6 billion respectively.

In the recent months, the company faced issues with US drug regulator for reported violation of manufacturing norms for injectibles that were supplied to US-based Sagent Pharma and Pfizer Inc.

SO it looks like a shady company.It took so much time for it get SEBI clearance.

Dear friends,

Peeping in from a relaive's house as I said earlier.

The price band of Claris is 278 to 293. It has an EPS of 25.8 for '09 and so is coming at a PE ratio of 11.4. The book value is 141.9 and so it will be at 2 times of the book value.

With Sun Pharma at a PE of 51, Lupin at 33, Biocon at 32, Torrent at 22 and Cadila and Piramal at 21, is it not coming at an attractive PE ratio?

Of course there is a lot to be understood about its past. With the negative past and the positive pricing, which side our valuation scale will tilt? Positive or negative?

Dear Sreedhar, please comment.

maha meh the below messege is for lic housing finance

the Board of Directors of the Company at its meeting held on October 27, 2010, has approved subdivision of Equity shares of the Company of Rs. 10/- each into 5 equity shares of Rs. 2/- each.

The Board also decided to conduct postal ballot for obtaining approval of the shareholders to ensure greater participation of the shareholders in the above decision.

the date is not finalised for stock split

Sreedhar,
You have commented on Chemcho statement. Asalu chemcho ku telugu telusa. bachcha galatho tho neeku enti vetakaram.

I believe some new precedent may be created in Powergrid listing & hence do not support Ravi bangalore's 3 scenarios.As Alibhoy has said the shares will be given new series hence we may sell only on 26.

Salecha,
Great that you have applied by cheque.Please stop the cheque.Now there is no guarantee RPP will list in premium.